Big Pharma Cuts Obesity Drug Prices After Trump Pressure
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
A Bengaluru woman uncovers shocking ride-hailing fraud after catching a Rapido driver using a fake app to inflate fares. The company swiftly suspends the driver following her viral social media expose.
In a significant crackdown, the Directorate of Revenue Intelligence dismantled a sophisticated drug factory in Gujarat's Valsad district, seizing massive quantities of Alprazolam worth crores and arresting key operatives.
Danish pharmaceutical giant Novo Nordisk faces turbulent times as Q3 profits drop 27% despite Ozempic's success. The company announces massive restructuring with 9,000 job cuts worldwide. Get the inside story on what's happening behind the scenes.
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Discover how AgentForce's AI-powered platform is reshaping customer engagement in India's life sciences sector, eliminating burnout while boosting productivity by 40%.
Himachal Pradesh drug control authorities raid Baddi pharmaceutical facility after Rajasthan complaints reveal distribution of sub-standard medicines across seven districts, raising serious public health concerns.
Indian vaccine maker Bharat Biotech expands into high-growth CRDMO space with new subsidiary Nucelion Therapeutics, focusing on cutting-edge cell and gene therapies for cancer and rare diseases.
India's Supreme Court takes stern stance against sophisticated 'digital arrest' scams that have extorted over ₹3,000 crore from citizens. Learn how cybercriminals are using fake police identities to terrorize victims.
Indian exports to the US plummeted 37.5% amid 50% Trump tariffs, with smartphones and pharmaceuticals taking the biggest hit. Get the complete trade impact analysis.
GTRI report reveals devastating 37.5% decline in India's key exports to US, with smartphones, pharmaceuticals, and gems taking the hardest hit from American tariff policies.
Multiple blood pressure medications recalled after FDA detects potential cancer-causing impurities. Find out if your medication is affected and what steps to take immediately.
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Indian pharmaceutical giant Cipla reveals strategic leadership transition with Achin Gupta succeeding Umang Vohra as Global CEO in September 2024, marking a new era for the company.
Major pharmaceutical recall alert: FDA discovers carcinogenic impurity in popular blood pressure medications, affecting hundreds of thousands of patients across the US. Safety concerns prompt immediate withdrawal.
Pharmaceutical giant Eli Lilly raises full-year profit forecast as demand skyrockets for revolutionary weight-loss treatment Zepbound, sending shares climbing 7%.
A 72-year-old Pune man suffered fatal heart attack days after being traumatized by sophisticated digital arrest scam where fraudsters posed as police and narcotics officials.
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
A heartbreaking tragedy unfolds in Pune as an elderly man suffers fatal heart attack days after being traumatized by sophisticated 'digital arrest' cyber fraud. Read the shocking details of how scammers posing as police destroyed a family.
Shocking probe reveals Punjab doctor's de-addiction centres allegedly operated pill trafficking network while claiming to treat addiction. ED uncovers massive pharmaceutical diversion scheme.
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Pharmaceutical giant Eli Lilly partners with NVIDIA to deploy cutting-edge AI supercomputers that will accelerate drug development and transform pharmaceutical research.
Cyber criminals posing as police and enforcement officials trick a Bengaluru entrepreneur into paying massive sums by threatening fake PFI association charges in sophisticated phone scam.
The state of Texas has filed a lawsuit against Johnson & Johnson and its spin-off Kenvue, alleging the companies failed to warn consumers about potential autism risks associated with Tylenol use during pregnancy. This legal action comes just weeks after f
Sanofi India announces Deepak Arora as its new Managing Director, bringing extensive pharmaceutical experience to drive growth and innovation in the Indian healthcare market.